- Home
- ACRV vs NMTC Comparison
ACRV vs NMTC Comparison
Compare ACRV & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- NMTC
- Stock Information
- Founded
- ACRV 2018
- NMTC 2009
- Country
- ACRV United States
- NMTC United States
- Employees
- ACRV N/A
- NMTC N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- NMTC Medical/Dental Instruments
- Sector
- ACRV Health Care
- NMTC Health Care
- Exchange
- ACRV Nasdaq
- NMTC Nasdaq
- Market Cap
- ACRV 40.4M
- NMTC 33.8M
- IPO Year
- ACRV 2022
- NMTC N/A
- Fundamental
- Price
- ACRV $1.34
- NMTC $0.71
- Analyst Decision
- ACRV Buy
- NMTC Strong Buy
- Analyst Count
- ACRV 7
- NMTC 1
- Target Price
- ACRV $17.60
- NMTC $1.45
- AVG Volume (30 Days)
- ACRV 379.9K
- NMTC 178.3K
- Earning Date
- ACRV 08-12-2025
- NMTC 08-13-2025
- Dividend Yield
- ACRV N/A
- NMTC N/A
- EPS Growth
- ACRV N/A
- NMTC N/A
- EPS
- ACRV N/A
- NMTC N/A
- Revenue
- ACRV N/A
- NMTC $5,758,777.00
- Revenue This Year
- ACRV N/A
- NMTC $157.28
- Revenue Next Year
- ACRV N/A
- NMTC $41.79
- P/E Ratio
- ACRV N/A
- NMTC N/A
- Revenue Growth
- ACRV N/A
- NMTC 54.53
- 52 Week Low
- ACRV $1.05
- NMTC $0.40
- 52 Week High
- ACRV $10.16
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- ACRV 55.88
- NMTC 65.31
- Support Level
- ACRV $1.15
- NMTC $0.72
- Resistance Level
- ACRV $1.38
- NMTC $0.77
- Average True Range (ATR)
- ACRV 0.09
- NMTC 0.05
- MACD
- ACRV 0.02
- NMTC 0.01
- Stochastic Oscillator
- ACRV 83.33
- NMTC 82.02
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.